These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 29856361)
1. Lymphomatoid Granulomatosis with Isolated Cutaneous Lesions: Prolonged Remission After DA-EPOCH Protocol. Gupta VG; Gogia A; Sharma V; Mallick S Turk J Haematol; 2018 Aug; 35(3):213-214. PubMed ID: 29856361 [No Abstract] [Full Text] [Related]
2. Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial. Melani C; Dowdell K; Pittaluga S; Dunleavy K; Roschewski M; Song JY; Calattini S; Kawada JI; Price DA; Chattopadhyay PK; Roederer M; Lucas AN; Steinberg SM; Jaffe ES; Cohen JI; Wilson WH Lancet Haematol; 2023 May; 10(5):e346-e358. PubMed ID: 37011643 [TBL] [Abstract][Full Text] [Related]
3. Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas. Roswarski J; Roschewski M; Lucas A; Melani C; Pittaluga S; Jaffe ES; Steinberg SM; Waldmann TA; Wilson WH Leuk Lymphoma; 2018 Jun; 59(6):1466-1469. PubMed ID: 29032710 [No Abstract] [Full Text] [Related]
4. Lymphomatoid granulomatosis. Successful treatment with CHOP combination chemotherapy. Drasga RE; Williams SD; Wills ER; Roth LM; Einhorn LH Am J Clin Oncol; 1984 Feb; 7(1):75-80. PubMed ID: 6546471 [TBL] [Abstract][Full Text] [Related]
5. Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma. Chihara D; Westin JR; Miranda RN; Cheah CY; Oki Y; Turturro F; Romaguera JE; Neelapu SS; Nastoupil LJ; Fayad LE; Rodriguez MA; Fowler NH; Orlowski RZ; Wang M; Hagemeister FB; Medeiros LJ; Fanale MA Br J Haematol; 2017 Nov; 179(3):503-506. PubMed ID: 27378601 [No Abstract] [Full Text] [Related]
6. Syndrome of inappropriate antidiuretic hormone secretion associated with primary cutaneous anaplastic large cell lymphoma. Hirata Y; Yokote T; Nishiwaki U; Tsuji M; Hanafusa T Br J Haematol; 2012 May; 157(4):412. PubMed ID: 22409317 [No Abstract] [Full Text] [Related]
7. Long-term follow-up of dose-adjusted EPOCH plus rituximab (DA-EPOCH-R) in untreated patients with poor prognosis large B-cell lymphoma. A phase II study conducted by the Spanish PETHEMA Group. Purroy N; Bergua J; Gallur L; Prieto J; Lopez LA; Sancho JM; García-Marco JA; Castellví J; Montes-Moreno S; Batlle A; de Villambrosia SG; Carnicero F; Ferrando-Lamana L; Piris MA; Lopez A Br J Haematol; 2015 Apr; 169(2):188-98. PubMed ID: 25521006 [TBL] [Abstract][Full Text] [Related]
8. Fine needle aspiration biopsy of a cutaneous relapse of lymphomatoid granulomatosis. A case report. Vargas J; Arguelles M; Nevado M; de la Serna J; de Agustín P Acta Cytol; 1993; 37(2):205-8. PubMed ID: 8465642 [TBL] [Abstract][Full Text] [Related]
9. Lymphomatoid granulomatosis. A case for aggressive therapy. Jenkins TR; Zaloznik AJ Cancer; 1989 Sep; 64(6):1362-5. PubMed ID: 2475241 [TBL] [Abstract][Full Text] [Related]
10. [Preliminary outcome for patients with relapsed or resistant advanced non-Hodgkin's lymphoma treated by EPOCH regimen]. Huang HQ; Jiang WQ; Wang W; Zhou ZM; Xia ZJ; Lin XB; Li YH; Xu RH; Zhang L; Xu GC; Sun XF; Liu DG; He YJ; Guan ZZ Ai Zheng; 2003 Apr; 22(4):389-92. PubMed ID: 12703995 [TBL] [Abstract][Full Text] [Related]
11. Angiocentric lymphomatoid granulomatosis and severe hypogammaglobulinaemia. Váróczy L; Gergely L; Szakáll S; Illés A Haematologia (Budap); 2002; 32(4):535-41. PubMed ID: 12803130 [TBL] [Abstract][Full Text] [Related]
12. Lymphomatoid granulomatosis with pulmonary and gastrointestinal involvement. Kappen JH; van Zaanen HC; Snelder SM; van Tilburg AJ; Rudolphus A BMJ Case Rep; 2017 Feb; 2017():. PubMed ID: 28167690 [TBL] [Abstract][Full Text] [Related]
13. Successful treatment of lymphomatoid granulomatosis using cyclosporin-A after failure of intensive chemotherapy. Raez LE; Temple JD; Saldana M Am J Hematol; 1996 Nov; 53(3):192-5. PubMed ID: 8895691 [TBL] [Abstract][Full Text] [Related]
14. Defining the cost of cure: infertility among female survivors of lymphoma. Stern CJ; Seymour JF Leuk Lymphoma; 2006 Apr; 47(4):574-5. PubMed ID: 16886268 [No Abstract] [Full Text] [Related]
15. DA-EPOCH-R therapy for high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements in a patient with renal dysfunction. Mitobe M; Kawamoto K; Suzuki T; Suwabe T; Shibasaki Y; Masuko M; Inoue K; Miyoshi H; Ohshima K; Sone H; Takizawa J J Clin Exp Hematop; 2021 Mar; 61(1):42-47. PubMed ID: 33551436 [TBL] [Abstract][Full Text] [Related]
16. Cutaneous lesions of lymphomatoid granulomatosis. Brodell RT; Miller CW; Eisen AZ Arch Dermatol; 1986 Mar; 122(3):303-6. PubMed ID: 3954395 [TBL] [Abstract][Full Text] [Related]
17. Lymphomatoid granulomatosis: a case report with unique clinical and histopathologic features. Boone JM; Zhang D; Fan F Ann Clin Lab Sci; 2013; 43(2):181-5. PubMed ID: 23694794 [TBL] [Abstract][Full Text] [Related]
18. Dose-adjusted EPOCH plus rituximab is an effective regimen in patients with poor-prognostic untreated diffuse large B-cell lymphoma: results from a prospective observational study. García-Suárez J; Bañas H; Arribas I; De Miguel D; Pascual T; Burgaleta C Br J Haematol; 2007 Jan; 136(2):276-85. PubMed ID: 17233819 [TBL] [Abstract][Full Text] [Related]
19. Phase 1/2 study of alemtuzumab with dose-adjusted EPOCH in untreated aggressive T and NK cell lymphomas. Roswarski J; Roschewski M; Melani C; Pittaluga S; Lucas A; Steinberg SM; Jaffe ES; Waldmann TA; Wilson WH Leuk Lymphoma; 2019 Aug; 60(8):2062-2066. PubMed ID: 30626252 [TBL] [Abstract][Full Text] [Related]
20. Successful management with CHOP for pulmonary lymphomatoid granulomatosis in a dog. Hatoya S; Kumagai D; Takeda S; Yamamoto E; Nakanishi M; Kuwamura M; Sugiura K; Sasai H; Yamate J; Inaba T J Vet Med Sci; 2011 Apr; 73(4):527-30. PubMed ID: 21139353 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]